Jasper Therapeutics's total assets for Q3 2024 were $99.41M, a decrease of -12.74% from the previous quarter. JSPR total liabilities were $15.73M for the fiscal quarter, a 15.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.